209 related articles for article (PubMed ID: 34615811)
1. Suppression of ADAM8 attenuates angiotensin II-induced cardiac fibrosis and endothelial-mesenchymal transition via inhibiting TGF-β1/Smad2/Smad3 pathways.
Yao L; Shao W; Chen Y; Wang S; Huang D
Exp Anim; 2022 Feb; 71(1):90-99. PubMed ID: 34615811
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II induces connective tissue growth factor and collagen I expression via transforming growth factor-beta-dependent and -independent Smad pathways: the role of Smad3.
Yang F; Chung AC; Huang XR; Lan HY
Hypertension; 2009 Oct; 54(4):877-84. PubMed ID: 19667256
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II upregulates Kv1.5 expression through ROS-dependent transforming growth factor-beta1 and extracellular signal-regulated kinase 1/2 signalings in neonatal rat atrial myocytes.
Lu G; Xu S; Peng L; Huang Z; Wang Y; Gao X
Biochem Biophys Res Commun; 2014 Nov; 454(3):410-6. PubMed ID: 25451261
[TBL] [Abstract][Full Text] [Related]
4. Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-β-mediated Smad3 phosphorylation.
Chen H; Yang T; Wang MC; Chen DQ; Yang Y; Zhao YY
Phytomedicine; 2018 Mar; 42():207-218. PubMed ID: 29655688
[TBL] [Abstract][Full Text] [Related]
5. A disintegrin and metalloproteinase 8 induced epithelial-mesenchymal transition to promote the invasion of colon cancer cells via TGF-β/Smad2/3 signalling pathway.
Jin Q; Jin X; Liu T; Lu X; Wang G; He N
J Cell Mol Med; 2020 Nov; 24(22):13058-13069. PubMed ID: 32954649
[TBL] [Abstract][Full Text] [Related]
6. Klotho inhibits angiotensin II-induced cardiac hypertrophy, fibrosis, and dysfunction in mice through suppression of transforming growth factor-β1 signaling pathway.
Ding J; Tang Q; Luo B; Zhang L; Lin L; Han L; Hao M; Li M; Yu L; Li M
Eur J Pharmacol; 2019 Sep; 859():172549. PubMed ID: 31325434
[TBL] [Abstract][Full Text] [Related]
7. Crosstalk between endothelial cell-specific calpain inhibition and the endothelial-mesenchymal transition via the HSP90/Akt signaling pathway.
Sun X; Sun Y; Jiang P; Qi G; Chen X
Biomed Pharmacother; 2020 Apr; 124():109822. PubMed ID: 31958767
[TBL] [Abstract][Full Text] [Related]
8. MFGE8 is down-regulated in cardiac fibrosis and attenuates endothelial-mesenchymal transition through Smad2/3-Snail signalling pathway.
Wang B; Ge Z; Wu Y; Zha Y; Zhang X; Yan Y; Xie Y
J Cell Mol Med; 2020 Nov; 24(21):12799-12812. PubMed ID: 32945126
[TBL] [Abstract][Full Text] [Related]
9. TGF-β1-induced SMAD2/3/4 activation promotes RELM-β transcription to modulate the endothelium-mesenchymal transition in human endothelial cells.
Jiang Y; Zhou X; Hu R; Dai A
Int J Biochem Cell Biol; 2018 Dec; 105():52-60. PubMed ID: 30120989
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of microRNA-21 mediates Ang II-induced renal fibrosis by activating the TGF-β1/Smad3 pathway via suppressing PPARα.
Lyu H; Li X; Wu Q; Hao L
J Pharmacol Sci; 2019 Sep; 141(1):70-78. PubMed ID: 31611175
[TBL] [Abstract][Full Text] [Related]
11. Qingda granule attenuates cardiac fibrosis via suppression of the TGF-β1/Smad2/3 signaling pathway in vitro and in vivo.
Chen X; Long L; Cheng Y; Chu J; Shen Z; Liu L; Li J; Xie Q; Liu H; Wu M; Chen Y; Peng J; Shen A
Biomed Pharmacother; 2021 May; 137():111318. PubMed ID: 33556875
[TBL] [Abstract][Full Text] [Related]
12. A novel role of kallikrein-related peptidase 8 in the pathogenesis of diabetic cardiac fibrosis.
Du JK; Yu Q; Liu YJ; Du SF; Huang LY; Xu DH; Ni X; Zhu XY
Theranostics; 2021; 11(9):4207-4231. PubMed ID: 33754057
[No Abstract] [Full Text] [Related]
13. Endothelial-specific deletion of Ets-1 attenuates Angiotensin II-induced cardiac fibrosis via suppression of endothelial-to-mesenchymal transition.
Xu L; Fu M; Chen D; Han W; Ostrowski MC; Grossfeld P; Gao P; Ye M
BMB Rep; 2019 Oct; 52(10):595-600. PubMed ID: 30670148
[TBL] [Abstract][Full Text] [Related]
14. SIRT1 activation attenuates cardiac fibrosis by endothelial-to-mesenchymal transition.
Liu ZH; Zhang Y; Wang X; Fan XF; Zhang Y; Li X; Gong YS; Han LP
Biomed Pharmacother; 2019 Oct; 118():109227. PubMed ID: 31351433
[TBL] [Abstract][Full Text] [Related]
15. Blockage of AKAP12 accelerates angiotensin II (Ang II)-induced cardiac injury in mice by regulating the transforming growth factor β1 (TGF-β1) pathway.
Li Y; Yu QH; Chu Y; Wu WM; Song JX; Zhu XB; Wang Q
Biochem Biophys Res Commun; 2018 May; 499(2):128-135. PubMed ID: 29501491
[TBL] [Abstract][Full Text] [Related]
16. Velvet antler peptide prevents pressure overload-induced cardiac fibrosis via transforming growth factor (TGF)-β1 pathway inhibition.
Zhao L; Mi Y; Guan H; Xu Y; Mei Y
Eur J Pharmacol; 2016 Jul; 783():33-46. PubMed ID: 27108788
[TBL] [Abstract][Full Text] [Related]
17. FOXF1 ameliorates angiotensin II-induced cardiac fibrosis in cardiac fibroblasts through inhibiting the TGF-β1/Smad3 signaling pathway.
Jin D; Han F
J Recept Signal Transduct Res; 2020 Dec; 40(6):493-500. PubMed ID: 32496870
[TBL] [Abstract][Full Text] [Related]
18. Exogenous angiotensin (1-7) directly inhibits epithelial-mesenchymal transformation induced by transforming growth factor-β1 in alveolar epithelial cells.
Shao M; Wen ZB; Yang HH; Zhang CY; Xiong JB; Guan XX; Zhong WJ; Jiang HL; Sun CC; Luo XQ; He XF; Zhou Y; Guan CX
Biomed Pharmacother; 2019 Sep; 117():109193. PubMed ID: 31387171
[TBL] [Abstract][Full Text] [Related]
19. MALAT1 Modulates TGF-β1-Induced Endothelial-to-Mesenchymal Transition through Downregulation of miR-145.
Xiang Y; Zhang Y; Tang Y; Li Q
Cell Physiol Biochem; 2017; 42(1):357-372. PubMed ID: 28535533
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of Nrf2/HO-1 and inhibition of TGF-β1/Smad2/3 signaling axis by daphnetin alleviates transverse aortic constriction-induced cardiac remodeling in mice.
Syed AM; Kundu S; Ram C; Kulhari U; Kumar A; Mugale MN; Mohapatra P; Murty US; Sahu BD
Free Radic Biol Med; 2022 Jun; 186():17-30. PubMed ID: 35513128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
